These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32564641)

  • 1. Benefits of prolonged infusion of beta-lactam antibiotics in patients with sepsis: personal perspectives.
    Rafailidis PI; Falagas ME
    Expert Rev Anti Infect Ther; 2020 Oct; 18(10):957-966. PubMed ID: 32564641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. A Meta-analysis of Individual Patient Data from Randomized Trials.
    Roberts JA; Abdul-Aziz MH; Davis JS; Dulhunty JM; Cotta MO; Myburgh J; Bellomo R; Lipman J
    Am J Respir Crit Care Med; 2016 Sep; 194(6):681-91. PubMed ID: 26974879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III.
    Lipman J; Brett SJ; De Waele JJ; Cotta MO; Davis JS; Finfer S; Glass P; Knowles S; McGuinness S; Myburgh J; Paterson DL; Peake S; Rajbhandari D; Rhodes A; Roberts JA; Shirwadkar C; Starr T; Taylor C; Billot L; Dulhunty JM
    Crit Care Resusc; 2019 Mar; 21(1):63-68. PubMed ID: 30857514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta lactam antibiotics and the question of dose regimen for severe infection. Prolonged infusion theoretically appealing--yet no evidence of clinical benefit].
    Leander G; Eliasson E; Hanberger H; Giske C
    Lakartidningen; 2015 Mar; 112():. PubMed ID: 25803536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis.
    Dulhunty JM; Roberts JA; Davis JS; Webb SA; Bellomo R; Gomersall C; Shirwadkar C; Eastwood GM; Myburgh J; Paterson DL; Starr T; Paul SK; Lipman J;
    Am J Respir Crit Care Med; 2015 Dec; 192(11):1298-305. PubMed ID: 26200166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial.
    Dulhunty JM; Roberts JA; Davis JS; Webb SA; Bellomo R; Gomersall C; Shirwadkar C; Eastwood GM; Myburgh J; Paterson DL; Lipman J
    Clin Infect Dis; 2013 Jan; 56(2):236-44. PubMed ID: 23074313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtleties in practical application of prolonged infusion of β-lactam antibiotics.
    De Waele JJ; Lipman J; Carlier M; Roberts JA
    Int J Antimicrob Agents; 2015 May; 45(5):461-3. PubMed ID: 25749200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended infusion of beta-lactam antibiotics: optimizing therapy in critically-ill patients in the era of antimicrobial resistance.
    Rizk NA; Kanafani ZA; Tabaja HZ; Kanj SS
    Expert Rev Anti Infect Ther; 2017 Jul; 15(7):645-652. PubMed ID: 28657373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis.
    Abdul-Aziz MH; Sulaiman H; Mat-Nor MB; Rai V; Wong KK; Hasan MS; Abd Rahman AN; Jamal JA; Wallis SC; Lipman J; Staatz CE; Roberts JA
    Intensive Care Med; 2016 Oct; 42(10):1535-1545. PubMed ID: 26754759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II study.
    Dulhunty JM; Roberts JA; Davis JS; Webb SA; Bellomo R; Gomersall C; Shirwadkar C; Eastwood GM; Myburgh J; Paterson DL; Starr T; Udy AA; Paul SK; Lipman J; ;
    Crit Care Resusc; 2013 Sep; 15(3):179-85. PubMed ID: 23944203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detailed regimens for the prolonged β-lactam infusion therapy.
    Hagiya H
    J Infect Chemother; 2024 Dec; 30(12):1324-1326. PubMed ID: 38977073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients.
    Veiga RP; Paiva JA
    Crit Care; 2018 Sep; 22(1):233. PubMed ID: 30244674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Pharmacodynamics of Prolonged Infusion β-Lactams for the Treatment of Pseudomonas aeruginosa Infections: A Systematic Review.
    Thabit AK; Hobbs ALV; Guzman OE; Shea KM
    Clin Ther; 2019 Nov; 41(11):2397-2415.e8. PubMed ID: 31679822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous-infusion beta-lactam antibiotics during continuous venovenous hemofiltration for the treatment of resistant gram-negative bacteria.
    Moriyama B; Henning SA; Neuhauser MM; Danner RL; Walsh TJ
    Ann Pharmacother; 2009 Jul; 43(7):1324-37. PubMed ID: 19584386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged infusion antibiotics for suspected gram-negative infections in the ICU: a before-after study.
    Arnold HM; Hollands JM; Skrupky LP; Smith JR; Juang PH; Hampton NB; McCormick S; Reichley RM; Hoban A; Hoffmann J; Micek ST; Kollef MH
    Ann Pharmacother; 2013 Feb; 47(2):170-80. PubMed ID: 23341160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should β-lactam antibiotics be administered by continuous infusion in critically ill patients? A survey of Australia and New Zealand intensive care unit doctors and pharmacists.
    Cotta MO; Dulhunty JM; Roberts JA; Myburgh J; Lipman J
    Int J Antimicrob Agents; 2016 Jun; 47(6):436-8. PubMed ID: 27179814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged administration of β-lactam antibiotics - a comprehensive review and critical appraisal.
    Osthoff M; Siegemund M; Balestra G; Abdul-Aziz MH; Roberts JA
    Swiss Med Wkly; 2016; 146():w14368. PubMed ID: 27731492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does prolonged β-lactam infusions improve clinical outcomes compared to intermittent infusions? A meta-analysis and systematic review of randomized, controlled trials.
    Tamma PD; Putcha N; Suh YD; Van Arendonk KJ; Rinke ML
    BMC Infect Dis; 2011 Jun; 11():181. PubMed ID: 21696619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of extended infusion β-lactams in the treatment of bloodstream infections in patients with liver cirrhosis.
    Bartoletti M; Lewis RE; Giannella M; Tedeschi S; Viale P
    Expert Rev Anti Infect Ther; 2018 Oct; 16(10):771-779. PubMed ID: 30221562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between augmented renal clearance and clinical outcomes in patients receiving β-lactam antibiotic therapy by continuous or intermittent infusion: a nested cohort study of the BLING-II randomised, placebo-controlled, clinical trial.
    Udy AA; Dulhunty JM; Roberts JA; Davis JS; Webb SAR; Bellomo R; Gomersall C; Shirwadkar C; Eastwood GM; Myburgh J; Paterson DL; Starr T; Paul SK; Lipman J; ;
    Int J Antimicrob Agents; 2017 May; 49(5):624-630. PubMed ID: 28286115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.